Taking stance against the challenges of communicable diseases and antimicrobial resistance

DOI: https://doi.org/10.13181/mji.v28i3.4219
Keywords: Editorial
Abstract viewed: 803 times
PDF downloaded: 781 times
HTML downloaded: 109 times
EPUB downloaded: 323 times

Abstract

[None]

References

  1. Ilyas EI, Irawati D, Elfiza D, Nurlaela C, Jusman SW, Kartinah NT. The potency of Hibiscus sabdariffa Linn. on decreased memory function related to the level of BDNF and CREB in hippocampus of overtrained rats. Int J Recent Sci Res. 2017;8(5):17097-103. https://doi.org/10.24327/ijrsr.2017.0805.0281

  2. World Health Organization [Internet]. Antimicrobial resistance. 2018 [cited 2019 Sept 2]. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

  3. Arianti A, Setiabudy R, Rozaliyani A, Siregar NC, Susiyanti M. Comparison of intravitreal antifungal 100 μg voriconazole and 5 μg amphotericin B in experimental Aspergillus flavus endophthalmitis model in rabbits. Med J Indones. 2019;28(3):215-22. https://doi.org/10.13181/mji.v28i3.4219

  4. Cannon JP, Fiscella R, Pattharachayakul S, Garey KW, De Alba F, Piscitelli S, et al. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Invest Ophthalmol Vis Sci. 2003;44(5):2112-7. https://doi.org/10.1167/iovs.02-1020

  5. Bae JH, Lee SC. Intravitreal liposomal amphotericin B for treatment of endogenous candida endophthalmitis. Jpn J Ophthalmol. 2015;59(5):346-52. https://doi.org/10.1007/s10384-015-0397-x

  6. Husnun A. Profil farmakokinetik dan uji efektifitas tetes mata amfoterisin B liposom pada keratomikosis kelinci [dissertation]. Jakarta (Indonesia): Universitas Indonesia; 2015. Indonesian.

Published
2019-10-04
How to Cite
1.
Freisleben H-J. Taking stance against the challenges of communicable diseases and antimicrobial resistance. Med J Indones [Internet]. 2019Oct.4 [cited 2023Apr.2];28(3):205-6. Available from: https://mji.ui.ac.id/journal/index.php/mji/article/view/4219
Issue
Vol 28 No 3 (2019): September
Section
Editorial

Copyright (c) 2019 Hans-Joachim Freisleben

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.